Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Drugs Recalls
Prescription and over-the-counter medications
CGMP Deviations: Out of Specification for Total Aerobic Microbial Count (TAMC) test for unfiltered bulk for decitabine for injection.
CGMP Deviations and Presence of Particulate Matter: Glass
CGMP deviations
CGMP deviations
CGMP deviations
Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.
Eszopiclone Tablets, USP 1mg CIV, 30-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, NDC 55111-629-30
Dr. Reddy's Laboratories
Failed Impurities/Degradation Specifications: Related Substances
Marketed Without an Approved NDA/ANDA: Products contain undeclared sildenafil.
CGMP deviations
Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Lack of Assurance of Sterility-The potential for incomplete crimp seals.
Discoloration: Brownish tablets
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
Progesterone 200 mg, Compounded, 90-count bottle, Rx, Dissolve One Sublingual Tablet After Dinner Nightly, AnazaoHealth, 5710 Hoover Blvd, Tampa, Fl 33643, (800)-995-4363. Beyond Use Date: 09/08/2024.
Coast Quality Pharmacy, LLC
Presence of Foreign Substance; Broken metal piece found embedded in tablet.
Sub-potent Drug
Marketed Without An Approved NDA/ANDA: FDA laboratory analysis found the product to contain undeclared diclofenac and methocarbamol,
Failed Content Uniformity Specifications
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.